Acute myocardial infarction and muscle salvage: a potential role for pharmacological agents.
D000241:Adenosine / Q000627:therapeutic use; D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000818:Animals; D001243:Assisted Circulation; D003097:Collateral Circulation; D001026:Coronary Artery Bypass; D003326:Coronary Circulation; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004558:Electric Stimulation; D005938:Glucocorticoids / Q000627:therapeutic use; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D007511:Ischemia / Q000188:drug therapy; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000601:surgery; D009206:Myocardium / Q000378:metabolism / Q000473:pathology; D009336:Necrosis; D005996:Nitroglycerin / Q000627:therapeutic use; D010100:Oxygen / Q000627:therapeutic use; D010101:Oxygen Consumption; D011188:Potassium / Q000627:therapeutic use; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use; D014693:Ventricular Fibrillation / Q000209:etiology
D000316:Adrenergic alpha-Agonists; D004071:Digitalis Glycosides; D004232:Diuretics; D005938:Glucocorticoids; D007328:Insulin; D011433:Propranolol; D006821:Hyaluronoglucosaminidase; D005996:Nitroglycerin; D005947:Glucose; D000241:Adenosine; D011188:Potassium; D010100:Oxygen